Healthcare -
Biotechnology - NASDAQ - US
$ 21.4
3.68 %
$ 1.9 B
Market Cap
-5.26
P/E
Price Target
Average
1.47%
Revenue Forecast
Estimate
51.47%
EBIT
Estimate
--31.72%
Net Income
Estimate
36.02%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Travere Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for TVTX of $21.7 , with forecasts ranging from
a
low of
$12 to a high of $33 .
TVTX Lowest Price Target
Wall Street Target
12 USD
-43.93%
TVTX Average Price Target
Wall Street Target
21.7 USD
1.47%
TVTX Highest Price Target
Wall Street Target
33 USD
54.21%
REVENUE FORECAST
Revenue Forecast Chart TVTX
EBIT FORECAST
EBIT Forecast Chart TVTX
NET INCOME FORECAST
Net Income Chart TVTX